What happens when you stop taking a weight loss drug? Many people gain the weight back.

 Artemis Bayandor, 40, has been attempting to get more fit throughout the previous 20 years.

She didn't make progress until her primary care physician recommended Wegovy, a weight reduction drug, in August 2021. She shed 15 pounds in around a half year.

Yet, everything halted in February, when Bayandor's health care coverage denied her inclusion, driving her to quit taking the prescription. After a month, she had recovered the 15 pounds, trailed by 10 additional pounds a half year after the fact.

"It was somewhat of a brain f — ," said Bayandor, of Naperville, Illinois.

Artemis Bayandor shed 15 pounds when she was taking Wegovy.Artemis Bayandor

Bayandor's experience is entirely expected: Far reaching deficiencies of Wegovy, a famous weight reduction help, have constrained certain individuals in the U.S. to quit taking it, driving them to acquire some — or all — of their weight back. Others have quit taking it for various reasons, for example, cost, disagreeable incidental effects or irrelevant medical problems.

Dr. Domenica Rubino, the overseer of the Washington Community for Weight The executives and Exploration in Arlington, Virginia, said the weight gain in individuals who quit taking the medication "appears to be legit."

Rubino drove a recent report, distributed in the Diary of the American Clinical Affiliation, that found that individuals who took Wegovy recaptured 66% of the weight they had lost when they went off the medication.

Weight is a persistent disease, she said. Likewise with some other persistent ailment, most patients should accept the drug for their whole lives to keep up with the advantages, which, for this situation, implies keeping the load off.

"They are ongoing meds," she said, "and that implies you essentially take them very much like you take circulatory strain medication or diabetes medication."

Wegovy, or semaglutide, is important for a class of medications called GLP-1 agonists. They impersonate a chemical that Diminishes food admission and cuts hunger. In clinical preliminaries, Wegovy was displayed to diminish body weight by around 15%.

Individuals who quit taking the medication might see that their cravings return to the levels they encountered before they took it, said Dr. Holly Lofton, the head of the weight the board program at NYU Langone Wellbeing. Now and again, she said, their cravings might feel considerably greater than they were before they lost the weight.

"At the point when you're at that maximum weight reduction, your body's appetite chemicals are the most elevated," she said. "So assuming that you shed 50 pounds and recover 25, your yearning is the most elevated when you've lost the 50. Also, in any event, when you recover the 25, it doesn't return to benchmark; your yearning is higher than before getting thinner."

Eli Diaz, 35, of Naples, Florida, said her primary care physician previously recommended Ozempic in February prior to exchanging her over to Wegovy a month after the fact. She additionally made some way of life changes, including adjusting her eating regimen and exercise. (Ozempic and Wegovy are a similar medication, semaglutide. It's sold under the name Ozempic for diabetes and, at a higher portion, as Wegovy for weight reduction.)

From February to May, Diaz shed 22 pounds.

In May, an irrelevant thyroid issue handled her in the clinic and constrained her to quit taking Wegovy.

Over the course of the following a half year, she recovered the entirety of the weight.

"It was normal, since I didn't proceed with the prescription or the eating routine subsequently," she said.

Lofton noticed that regardless of Wegovy, a solid eating regimen and exercise are significant for weight upkeep.

Diaz said she's thinking about beginning again on the medication. "I'm willing to begin soon once more and check whether, you know, assuming that they will help me in the future," she said.

Restarting the prescription some of the time is certainly not a simple undertaking, said Dr. Susan Spratt, an endocrinologist and the senior clinical chief for the Populace Wellbeing The board Office at Duke Wellbeing in North Carolina.

Since Wegovy can accompany secondary effects, for example, queasiness or regurgitating, patients are many times initially endorsed a lower portion that is progressively expanded more than a little while.

"That is truly oppressive," she said.

Bayandor, the Illinois lady, said she stresses regarding the secondary effects. She said it required her a half year before she arrived at the most Noteworthy portion.

"Truly, I'm apprehensive," she said of restarting the medicine. "At the point when I was on it, it felt burdening on my body."

She said she intends to see a weight Reduction doctor one month from now before she chooses whether to get back on the medicine, in the event that she can bear the cost of it.

"It is a particularly extraordinary and strong medication," she said.

Follow NBC Wellbeing on Twitter and Facebook.